TransMedics Group Inc. (NASDAQ:TMDX) Combines Strong Growth with Bullish Technical Momentum

Last update: Jan 31, 2026

For investors aiming to achieve major capital gains, a plan that joins solid fundamental growth with positive technical momentum can be an effective method. The process centers on finding firms that are not only increasing their earnings and sales at a fast rate but are also showing price behavior that points to institutional buying and a possible move out of a holding pattern. This two-part study seeks to locate shares where sound business foundations are being acknowledged by the market, which may result in continued rising price trends. One stock that recently appeared from this kind of filter is TRANSMEDICS GROUP INC (NASDAQ:TMDX).

TransMedics Group Inc. stock chart

Fundamental Growth Engine

Fundamentally, this plan requires outstanding growth, and TransMedics meets this need clearly. The company’s fundamental report shows a business in a state of very fast growth, receiving a high Growth Rating. The numbers are clear:

  • High Earnings Growth: Earnings Per Share (EPS) increased by 162.77% over the last year.
  • Fast Revenue Increase: Revenue rose 41.20% in the last year and has been building at an average yearly rate of almost 80% over recent years.
  • Positive Future Projection: Analysts anticipate this pace to persist, with estimated EPS growth of 33.25% and revenue growth of 21.23% each year in the near future.

This growth is important because it supplies the fundamental reason for possible share price increases. Firms growing this fast are often putting earnings back into the business to gain more market position, which is a sign of profitable growth investment. While the company’s Profitability and Financial Health ratings are moderate, they are backed by solid basic measures like very good return on equity and sound current and quick ratios, showing it is financing its growth from a place of acceptable financial strength. You can see the complete details in the detailed fundamental analysis report for TMDX.

Technical Setup and Momentum

A positive growth narrative must be paired with encouraging market behavior to indicate a good time to enter. The technical study for TransMedics shows a stock that is stabilizing its large advances and could be getting ready for its next upward move.

  • Long-Term Upward Trend Remains: The long-term trend is decidedly positive, with the stock priced well above its important moving averages (50-day, 100-day, and 200-day).
  • Positive Relative Performance: TMDX has done better than 93% of all stocks and 94% of its healthcare equipment competitors over the past year, showing clear market strength.
  • Stabilization Close to Highs: The stock is now trading in the high part of its 52-week range, having declined from its top. This recent stabilization inside a set range has formed a possible pattern.
  • Pocket Pivot Signal: A recent "Pocket Pivot" signal, where price rises on volume greater than the highest down volume of the previous 10 days, indicates quiet buying.

The technical report mentions a defined resistance area just above the present price. A clear move above this area could mark the finish of the stabilization period and the start of a new rising trend, matching the technical view with the strong fundamental growth story. The full technical view, including exact support and resistance points, is found in the technical analysis report for TMDX.

Valuation Considerations

Growth at any cost is not the aim. TransMedics sells at a high level based on standard measures like its Price/Earnings ratio, which is expected given its growth characteristics. However, when measured against its industry group, the price appears more acceptable. The main point for growth investors is if the high growth rate can support the current price. The company’s low PEG ratio, which includes earnings growth, implies the market may not be completely valuing its future growth possibility, providing some room for error for investors focused on growth.

Conclusion

TransMedics Group makes a strong argument for the growth-with-momentum plan. The company is performing well, changing the organ transplant logistics field with its exclusive Organ Care System and displaying financial outcomes that rank it in the leading group of growth firms. Technically, the stock is behaving positively, keeping advances and forming a pattern that frequently comes before more progress. For investors, this pairing indicates a company whose fundamental advancement is being seen in its share price activity, deserving further examination.

This stock was found using a filter for strong growth stocks with positive technical patterns. If this process matches your investment style, you can locate more possible choices using this screening tool.


Disclaimer: This article is for informational purposes only and does not constitute financial advice, a recommendation, or an offer or solicitation to buy or sell any securities. The analysis is based on data and reports believed to be reliable, but its accuracy cannot be guaranteed. Investing involves risk, including the potential loss of principal. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

TRANSMEDICS GROUP INC

NASDAQ:TMDX (1/30/2026, 8:21:29 PM)

After market: 133.5 -0.47 (-0.35%)

133.975

-5 (-3.59%)



Find more stocks in the Stock Screener

Follow ChartMill for more
Follow us on StockTwitsFollow us on InstagramFollow us on FacebookFollow us on YouTube